3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Ovarian Neoplasms
4
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Testicular Germ Cell Tumor
2
Neuroblastoma
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Optic Nerve Glioma
1
Interventions
Colposcopy
18
Imiquimod
14
Conization
12
Papillomavirus Vaccines
9
Vaccines
7
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
7
Cryotherapy
7
Biopsy
6
Acetic Acid
6
human papillomavirus vaccine, L1 type 16, 18
5
Vaginal Smears
5
Papanicolaou Test
5
Human Papillomavirus DNA Tests
5
Blood Specimen Collection
5
Watchful Waiting
4
GX-188 vaccine
4
Surveys and Questionnaires
3
Cisplatin
3
VGX-3100
2
Transurethral Resection of Prostate
2
Topotecan
2
Spectrometry, Fluorescence
2
Restraint, Physical
2
Proflavine
2
Polymerase Chain Reaction
2
Paclitaxel
2
Mass Screening
2
Indomethacin
2
Immunohistochemistry
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Microarray Analysis
×
Gynecologic
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled